Molecular  ||| S:0 E:10 ||| JJ
pathogenesis  ||| S:10 E:23 ||| NN
of  ||| S:23 E:26 ||| IN
primary  ||| S:26 E:34 ||| JJ
hyperparathyroidism  ||| S:34 E:54 ||| JJ
Primary  ||| S:54 E:62 ||| JJ
hyperparathyroidism  ||| S:62 E:82 ||| NNS
( ||| S:82 E:83 ||| -LRB-
PHPT ||| S:83 E:87 ||| NNP
)  ||| S:87 E:89 ||| -RRB-
is  ||| S:89 E:92 ||| VBZ
a  ||| S:92 E:94 ||| DT
common  ||| S:94 E:101 ||| JJ
endocrinopathy ||| S:101 E:115 ||| NN
,  ||| S:115 E:117 ||| ,
mostly  ||| S:117 E:124 ||| RB
caused  ||| S:124 E:131 ||| VBN
by  ||| S:131 E:134 ||| IN
a  ||| S:134 E:136 ||| DT
monoclonal  ||| S:136 E:147 ||| JJ
parathyroid  ||| S:147 E:159 ||| JJ
adenoma ||| S:159 E:166 ||| NN
.  ||| S:166 E:168 ||| .
The  ||| S:168 E:172 ||| DT
hereditary  ||| S:172 E:183 ||| JJ
syndromes  ||| S:183 E:193 ||| NNS
include  ||| S:193 E:201 ||| VBP
multiple  ||| S:201 E:210 ||| JJ
endocrine  ||| S:210 E:220 ||| JJ
neoplasia  ||| S:220 E:230 ||| JJ
types  ||| S:230 E:236 ||| NNS
1  ||| S:236 E:238 ||| CD
( ||| S:238 E:239 ||| -LRB-
MEN  ||| S:239 E:243 ||| NNP
1 ||| S:243 E:244 ||| CD
)  ||| S:244 E:246 ||| -RRB-
and  ||| S:246 E:250 ||| CC
2A  ||| S:250 E:253 ||| NNP
( ||| S:253 E:254 ||| -LRB-
MEN  ||| S:254 E:258 ||| NNP
2A ||| S:258 E:260 ||| NNP
) ||| S:260 E:261 ||| -RRB-
,  ||| S:261 E:263 ||| ,
hereditary  ||| S:263 E:274 ||| JJ
hyperparathyroidism-jaw  ||| S:274 E:298 ||| JJ
tumor  ||| S:298 E:304 ||| NN
( ||| S:304 E:305 ||| -LRB-
HPTJT ||| S:305 E:310 ||| NNP
) ||| S:310 E:311 ||| -RRB-
,  ||| S:311 E:313 ||| ,
familial  ||| S:313 E:322 ||| FW
isolated  ||| S:322 E:331 ||| FW
hyperparathyroidism  ||| S:331 E:351 ||| FW
( ||| S:351 E:352 ||| -LRB-
FIHP ||| S:352 E:356 ||| NNP
) ||| S:356 E:357 ||| -RRB-
,  ||| S:357 E:359 ||| ,
familial  ||| S:359 E:368 ||| FW
hypocalciuric  ||| S:368 E:382 ||| FW
hypercalcemia  ||| S:382 E:396 ||| FW
( ||| S:396 E:397 ||| -LRB-
FHH ||| S:397 E:400 ||| NNP
)  ||| S:400 E:402 ||| -RRB-
and  ||| S:402 E:406 ||| CC
neonatal  ||| S:406 E:415 ||| JJ
severe  ||| S:415 E:422 ||| JJ
hyperparathyroidism  ||| S:422 E:442 ||| NNS
( ||| S:442 E:443 ||| -LRB-
NSHPT ||| S:443 E:448 ||| NNP
) ||| S:448 E:449 ||| -RRB-
.  ||| S:449 E:451 ||| .
Mutations  ||| S:451 E:461 ||| NNS
of  ||| S:461 E:464 ||| IN
MEN1  ||| S:464 E:469 ||| NNP
and  ||| S:469 E:473 ||| CC
CDKN1B  ||| S:473 E:480 ||| CD
genes  ||| S:480 E:486 ||| NNS
are  ||| S:486 E:490 ||| VBP
responsible  ||| S:490 E:502 ||| JJ
for  ||| S:502 E:506 ||| IN
MEN  ||| S:506 E:510 ||| NNP
1  ||| S:510 E:512 ||| CD
in  ||| S:512 E:515 ||| IN
70-80 ||| S:515 E:520 ||| CD
%  ||| S:520 E:522 ||| NN
and  ||| S:522 E:526 ||| CC
about  ||| S:526 E:532 ||| IN
2 ||| S:532 E:533 ||| CD
%  ||| S:533 E:535 ||| NN
of  ||| S:535 E:538 ||| IN
cases ||| S:538 E:543 ||| NNS
,  ||| S:543 E:545 ||| ,
respectively ||| S:545 E:557 ||| RB
.  ||| S:557 E:559 ||| .
MEN1  ||| S:559 E:564 ||| NNP
and  ||| S:564 E:568 ||| CC
CDKN1B  ||| S:568 E:575 ||| CD
genes  ||| S:575 E:581 ||| NNS
have  ||| S:581 E:586 ||| VBP
also  ||| S:586 E:591 ||| RB
a  ||| S:591 E:593 ||| DT
role  ||| S:593 E:598 ||| NN
in  ||| S:598 E:601 ||| IN
the  ||| S:601 E:605 ||| DT
pathogenesis  ||| S:605 E:618 ||| NN
of  ||| S:618 E:621 ||| IN
sporadic  ||| S:621 E:630 ||| JJ
parathyroid  ||| S:630 E:642 ||| JJ
adenomas ||| S:642 E:650 ||| NN
.  ||| S:650 E:652 ||| .
HRPT2 ||| S:652 E:657 ||| NNP
/ ||| S:657 E:658 ||| NNP
CDC73  ||| S:658 E:664 ||| NNP
gene  ||| S:664 E:669 ||| NN
mutations  ||| S:669 E:679 ||| NNS
are  ||| S:679 E:683 ||| VBP
responsible  ||| S:683 E:695 ||| JJ
for  ||| S:695 E:699 ||| IN
HPT-JT  ||| S:699 E:706 ||| JJ
and  ||| S:706 E:710 ||| CC
sporadic  ||| S:710 E:719 ||| JJ
parathyroid  ||| S:719 E:731 ||| JJ
carcinoma ||| S:731 E:740 ||| NN
.  ||| S:740 E:742 ||| .
MEN1  ||| S:742 E:747 ||| NNP
and  ||| S:747 E:751 ||| CC
HRPT2 ||| S:751 E:756 ||| CD
/ ||| S:756 E:757 ||| CD
CDC73  ||| S:757 E:763 ||| CD
genes  ||| S:763 E:769 ||| NNS
mutations  ||| S:769 E:779 ||| NNS
have  ||| S:779 E:784 ||| VBP
also  ||| S:784 E:789 ||| RB
been  ||| S:789 E:794 ||| VBN
found  ||| S:794 E:800 ||| VBN
in  ||| S:800 E:803 ||| IN
a  ||| S:803 E:805 ||| DT
subset  ||| S:805 E:812 ||| NN
of  ||| S:812 E:815 ||| IN
FIHP  ||| S:815 E:820 ||| NNP
families ||| S:820 E:828 ||| NNS
.  ||| S:828 E:830 ||| .
FHH  ||| S:830 E:834 ||| NNP
and  ||| S:834 E:838 ||| CC
NSHPT  ||| S:838 E:844 ||| NNP
represent  ||| S:844 E:854 ||| VBP
the  ||| S:854 E:858 ||| DT
mildest  ||| S:858 E:866 ||| NN
and  ||| S:866 E:870 ||| CC
severest  ||| S:870 E:879 ||| JJ
variants  ||| S:879 E:888 ||| NN
of  ||| S:888 E:891 ||| IN
PHPT ||| S:891 E:895 ||| NNP
,  ||| S:895 E:897 ||| ,
caused  ||| S:897 E:904 ||| VBN
by  ||| S:904 E:907 ||| IN
heterozygous  ||| S:907 E:920 ||| NN
and  ||| S:920 E:924 ||| CC
homozygous  ||| S:924 E:935 ||| JJ
mutations  ||| S:935 E:945 ||| NNS
in  ||| S:945 E:948 ||| IN
the  ||| S:948 E:952 ||| DT
calcium  ||| S:952 E:960 ||| JJ
sensing  ||| S:960 E:968 ||| JJ
receptor  ||| S:968 E:977 ||| NN
( ||| S:977 E:978 ||| -LRB-
CASR ||| S:978 E:982 ||| NNP
)  ||| S:982 E:984 ||| -RRB-
gene ||| S:984 E:988 ||| NN
,  ||| S:988 E:990 ||| ,
respectively ||| S:990 E:1002 ||| RB
.  ||| S:1002 E:1004 ||| .
